With proper business development tools and insights into entrepreneurship, biomedical researchers can improve the potential of their discoveries in the laboratory reaching patients. I-Corps@NCATS, a University of Miami (UM) Clinical and Translational Science Institute (CTSI) program, helps entrepreneurial-minded researchers move their new drugs, diagnostics, technologies, and devices forward to the next stage of development.
The Research Advocacy and Quality Champions — a select group of UM’s very best Clinical Research Coordinators and Directors - meet once a month to advise the CTSI, Clinical Research Operations and Regulatory Support (CRORS), and the Human Subjects Research Office (HSRO) on system-level issues that can be improved to help study approval, start-up, and implementation activities go more smoothly.
Six Miami CTSI faculty have contributed articles to a newly released special issue of the Journal of Clinical and Translational Science on COVID-19. Explore the articles or read the entire online issue to discover the innovative ways the Clinical and Translational Science Awards (CTSA) program responded to the global health crisis.
Establishing a collaborative agreement for biostatistics support for the fiscal year will secure resources dedicated to your research from the Biostatistics Collaboration and Consulting Core (BCCC). Additionally, matching funds may be available through the Miami CTSI.